High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro

The use of high-dose ascorbate (ASC) for the treatment of human cancer has been attempted several decades ago and has been recently revived by several in vitro and in vivo studies in solid tumors. We tested the cytotoxic effects of ASC, alone or in combination with arsenic trioxide (ATO) in acute my...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Noguera, Nélida I., Pelosi, Elvira, Angelini, Daniela F., Piredda, Maria Liliana, Guerrera, Gisella, Piras, Eleonora, Battistini, Luca, Massai, Lauretta, Berardi, Anna, Catalano, Gianfranco, Cicconi, Laura, Castelli, Germana, D’Angiò, Agnese, Pasquini, Luca, Graziani, Grazia, Fioritoni, Giuseppe, Voso, Maria Teresa, Mastrangelo, Domenico, Testa, Ugo, Lo-Coco, Francesco
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2017
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464808/
https://ncbi.nlm.nih.gov/pubmed/28427227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15925
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים